Myriad Genetics Stock Story
| MYGN Stock | USD 18.51 0.13 0.70% |
About 68% of Myriad Genetics' investor base is looking to short. The analysis of the overall investor sentiment regarding Myriad Genetics suggests that many traders are alarmed. Myriad Genetics' investor sentiment overview provides quick insight into current market opportunities from investing in Myriad Genetics. The current market sentiment, together with Myriad Genetics' historical and current headlines, can help investors time the market. In addition, many technical investors use Myriad Genetics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Myriad Genetics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Myriad daily returns and investor perception about the current price of Myriad Genetics as well as its diversification or hedging effects on your existing portfolios.
Myriad |
Requested story not found. it has been either deleted or moved. View all stories for Myriad Genetics.
Myriad Genetics Latest Timeline
Myriad Genetics is listed for 18.51. About 98.0% of the company shares are owned by institutional investors. The book value of Myriad Genetics was now reported as 8.71. The company has Price/Earnings To Growth (PEG) ratio of 1.4. Myriad Genetics recorded a loss per share of 3.18. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 26th of March 2009.Check out Myriad Genetics Hype Analysis, Myriad Genetics Correlation and Myriad Genetics Performance. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.Note that the Myriad Genetics information on this page should be used as a complementary analysis to other Myriad Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Myriad Stock analysis
When running Myriad Genetics' price analysis, check to measure Myriad Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myriad Genetics is operating at the current time. Most of Myriad Genetics' value examination focuses on studying past and present price action to predict the probability of Myriad Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Myriad Genetics' price. Additionally, you may evaluate how the addition of Myriad Genetics to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Myriad Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.18) | Revenue Per Share 9.097 | Quarterly Revenue Growth 0.106 | Return On Assets (0.07) | Return On Equity (0.32) |
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.